⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL105805 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL4578644 | 0.97 | CHRNB2 (0.40) | — | |
| SCHEMBL22384141 | 0.84 | SLC22A6 (0.38) | — | |
| SCHEMBL9512873 | 0.80 | CHRNB2 (0.43) | — | |
| SCHEMBL8903486 | 0.78 | — | — | |
| SCHEMBL16846175 | 0.78 | — | — | |
| SCHEMBL1615800 | 0.78 | CHRNB2 (0.58) | — | |
| SCHEMBL1144278 | 0.77 | SLC22A6 (0.36) | — | |
| SCHEMBL29953499 | 0.77 | SLC22A6 (0.36) | — | |
| SCHEMBL8891481 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8748659-B2 | Method for producing alpha,beta-unsaturated carboxylic acid-N,N-disubstituted amide and method for producing 3-alkoxycarboxylic acid-N,N-disubstituted amide | IDEMITSU KOSAN CO., LTD. (JP) | 2014-06-10 | — | — | US | claimed |
| EP-2664610-A1 | Method for producing alpha,beta-unsaturated carboxylic acid-N,N-disubstituted amide and method for producing 3-alkoxycarboxylic acid-N,N-disubstituted amide | Idemitsu Kosan Co., Ltd (JP) | 2013-11-20 | — | — | EP | claimed |
| US-20120088931-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-04-12 | — | — | US | claimed |
| EP-2426103-A1 | METHOD FOR PRODUCING ALPHA, BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | Idemitsu Kosan Co., Ltd. (JP) | 2012-03-07 | — | — | EP | claimed |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-12304907-B2 | Compounds and methods of use | TANGO THERAPEUTICS, INC. (US) | 2025-05-20 | — | — | US | disclosed |
| US-12264154-B2 | Compounds and methods of use | TANGO THERAPEUTICS, INC. (US) | 2025-04-01 | — | — | US | disclosed |
| US-20240279219-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2024-08-22 | — | — | US | disclosed |
| US-20240228478-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2024-07-11 | — | — | US | disclosed |
| US-20240228478-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2024-07-11 | — | — | US | disclosed |
| US-11999727-B2 | Compounds and methods of use | TANGO THERAPEUTICS, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| CN-116568677-A | piperidin-1-yl-N-pyridin-3-yl-2-oxoacetamide derivatives useful for the treatment of MTAP deficiency and/or MTA accumulating cancers | 探戈医药股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| EP-2426103-A1 | METHOD FOR PRODUCING ALPHA, BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | Idemitsu Kosan Co., Ltd. (JP) | 2012-03-07 | — | — | EP | disclosed |
| US-8114611-B2 | Affinity chromatography matrices and methods of making and using the same | MILLIPORE CORPORATION (US) | 2012-02-14 | — | — | US | disclosed |
| US-20110105730-A1 | AFFINITY CHROMATOGRAPHY MATRICES AND METHODS OF MAKING AND USING THE SAME | MILLIPORE CORPORATION (US) | 2011-05-05 | — | — | US | disclosed |
| EP-1773450-A2 | THERAPEUTICALLY COMBINATIONS | Messadek, Jallal (BE) | 2007-04-18 | — | — | EP | disclosed |
| US-20060263399-A1 | Preparation for external use on skin | VIVIER CANADA INC. (CA) | 2006-11-23 | — | — | US | disclosed |
| US-20060039961-A1 | Percutaneous absorption accelerator | VIVIER CANADA INC. (CA) | 2006-02-23 | — | — | US | disclosed |
| US-20060030621-A1 | Preparation for external use on skin | VIVIER CANADA INC. (CA) | 2006-02-09 | — | — | US | disclosed |
| WO-2006007671-A2 | THERAPEUTICALLY COMBINATIONS | MESSADEK JALLAL (BE) | 2006-01-26 | — | — | WO | disclosed |